Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now

NasdaqCM - Nasdaq Real Time Price USD

UTime Limited (WTO)

Compare

0.2145

-0.0165

(-7.14%)

At close: March 4 at 4:00:00 PM EST

0.2095

-0.00

(-2.33%)

After hours: 7:08:03 PM EST

UTime First Half 2025 Earnings: CN¥192 loss per share (vs CN¥19.15 loss in 1H 2024)

UTime ( NASDAQ:WTO ) First Half 2025 Results Key Financial Results Revenue: CN¥138.4m (up 65% from 1H 2024). Net loss...

Simply Wall St. last month

WTO
-7.14%
UTime Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency

NEW YORK, Oct. 17, 2024 (GLOBE NEWSWIRE) -- UTime Limited (“UTime” or the “Company”) (Nasdaq: WTO), a mobile device manufacturing company committed to providing cost effective products and solutions to consumers globally and helping low-income individuals from established and emerging markets, announced today that on October 10, 2024, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”) notifying the Company that the mi

GlobeNewswire 4 months ago

WTO
-7.14%
UTime Limited Announces Pricing of $5 Million Registered Direct Offering

NEW YORK, Sept. 13, 2024 (GLOBE NEWSWIRE) -- UTime Limited (“UTime” or the “Company”) (Nasdaq: WTO), a mobile device manufacturing company committed to providing cost effective products and solutions to consumers globally and helping low-income individuals from established and emerging markets today announced that it has entered into a securities purchase agreement with certain accredited investor to sell $5 million of its ordinary shares in a registered direct offering. Under the terms of the s

GlobeNewswire 5 months ago

WTO
-7.14%
UTime Limited Announces 1-For-25 Reverse Share Split

NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- UTime Limited (“UTime” or the “Company”) (Nasdaq: WTO), a mobile device manufacturing company committed to providing cost effective products and solutions to consumers globally and helping low-income individuals from established and emerging markets today announced that it will effect a reverse share split of its outstanding ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), at a ratio of 1-for-25, to be effective on or around the o

GlobeNewswire 5 months ago

WTO
-7.14%
Remarkable Announcement on Significant Fluctuation of the UTime's Share Price

Dear Investors, Analysts and Media:

PR Newswire 6 months ago

WTO
-7.14%
UTime Signs NDA to Acquire Monkeypox Vaccine Maker Bowen Therapeutics Inc and Supports Completion of FDA Registration of Related Vaccines

UTime Limited (NASDAQ: WTO) ("UTime" or the "Company") has officially announced the signing of a non-disclosure agreement (the "NDA") with Bowen Therapeutics Inc ("Bowen Therapeutics") for the acquisition of the Bowen Therapeutics laboratory at UMASS Medical School. This strategic move not only marks UTime's in-depth expansion in the global vaccine market, but also provides strong support for the registration of the relevant vaccine through the U.S. Food and Drug Administration (the "FDA").

PR Newswire 6 months ago

WTO
-7.14%
UTime Limited Partners with Dr. Ehud Baron to Pioneer AI-Driven Health Solutions

UTime Limited (NASDAQ: WTO) ("UTime" or the "Company") is pleased to announce a Memorandum of Understanding ("MOU") with XCardio, a Japanese company owned by Dr. Ehud Baron, a leader in medical technology innovation. This partnership focuses on the joint development of state-of-the-art continuous blood pressure monitoring devices, BPWatch, aimed at advancing cardiovascular disease management. This joint project also aims to develop a new revenue model by transitioning from the low-margin busines

PR Newswire 6 months ago

WTO
-7.14%
UTime Limited Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) -- UTime Limited (“UTime” or the “Company”) (Nasdaq: WTO), a mobile device manufacturing company committed to providing cost effective products and solutions to consumers globally and helping low-income individuals from established and emerging markets, announced today that it received a formal notification from the Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires the Company’s

GlobeNewswire 6 months ago

WTO
-7.14%

Performance Overview

Return	WTO	S&P 500
YTD	-31.47%	-1.76%
1-Year	-96.38%	+12.61%
3-Year	-99.52%	+33.48%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

UTime Limited (WTO)

UTime First Half 2025 Earnings: CN¥192 loss per share (vs CN¥19.15 loss in 1H 2024)

UTime Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency

UTime Limited Announces Pricing of $5 Million Registered Direct Offering

UTime Limited Announces 1-For-25 Reverse Share Split

Remarkable Announcement on Significant Fluctuation of the UTime's Share Price

UTime Signs NDA to Acquire Monkeypox Vaccine Maker Bowen Therapeutics Inc and Supports Completion of FDA Registration of Related Vaccines

UTime Limited Partners with Dr. Ehud Baron to Pioneer AI-Driven Health Solutions

UTime Limited Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Performance Overview